
Immunotherapies Spark Excitement in Triple-Negative Breast Cancer Treatment
THE USE OF IMMUNOTHERAPY approaches in triple-negative breast cancer (TNBC) has resulted in diverse breakthroughs that leverage immune checkpoint inhibitors (ICIs). Expanded use of ICIs has led to the identification of different molecular subtypes that can …